2017
Dear Shareholders,
the Annual General Shareholders’ Meeting of Epigenomics AG has taken place on May 30, 2017 in Berlin. Shareholders approved all agenda items according to the Board’s proposal with approval rates between 77% and 91%.
| Invitation to the Annual General Shareholders’ Meeting 2017 of Epigenomics AG | |
| Report of the Executive Board on agenda items 4, 5, 6 and 7 | |
| Annual Report 2016 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
| Financial Statements 2016 (German HGB) incl. Key features of the internal control and risk management system (German version) |
|
| Explanatory Report by the Management Board on Disclosures Pursuant to Section 289 (4), Section 315 (4) HGB (German Version) | |
| Explanatory Report by the Management Board on Key Features of the Internal Control and Risk Management System Related to the Group Accounting Procedures of the Company Pursuant to Section 289 (5), Section 315 (2) HGB (German version) |
Corporate Governance/Declaration of Governance
| 2016 | |
| Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) | |
| Update to the Declaration of Compliance dated October 2016 with the German Corporate Governance Codex pursuant to Section 161 of the German Stock Corporation Act (AktG) | |
| Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
| Explanation of Shareholders’ rights | |
| Articles of Association | |
| Form for Voting Representation |